{"id":46005,"date":"2022-07-11T12:02:31","date_gmt":"2022-07-11T10:02:31","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/bruker-announces-three-new-ghz-nmr-systems-orders-for-functional-structural-biology-and-clinical-phenomics-research\/"},"modified":"2022-07-11T12:02:31","modified_gmt":"2022-07-11T10:02:31","slug":"bruker-announces-three-new-ghz-nmr-systems-orders-for-functional-structural-biology-and-clinical-phenomics-research","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/bruker-announces-three-new-ghz-nmr-systems-orders-for-functional-structural-biology-and-clinical-phenomics-research\/","title":{"rendered":"Bruker Announces Three New GHz NMR Systems Orders for Functional Structural Biology and Clinical Phenomics Research"},"content":{"rendered":"
\n

\nThree Labs in Japan and Spain to Receive Novel Compact Ascend Evo 1.0 GHz<\/i> Magnets<\/b>\n<\/p>\n

UTRECHT, The Netherlands–(BUSINESS WIRE)–$BRKR<\/a> #BRKR<\/a>–At the Euromar 2022<\/a> Conference, Bruker announced three new customer orders for GHz systems, which will incorporate novel, compact 1.0 GHz <\/i><\/b>NMR magnets for structural biology applications and clinical research in single-story laboratories. The new Ascend Evo 1.0 GHz<\/i><\/b> NMR magnet, operating at 4.2 Kelvin, allows functional <\/i>structural biology and clinical phenomics researchers to dive deeper into the structural details, binding and dynamics of molecular structures and complexes for fundamental cell biology and pathobiology research. It complements Bruker\u2019s Avance Neo <\/i>1.1 GHz and 1.2 GHz NMR systems with two-story 2 Kelvin magnets, which typically are used at shared national NMR facilities, such as the 1.2 GHz NMR at the Dutch Ultra-high Field Magnetic Resonance Consortium<\/i>, <\/b>operating at Utrecht University.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nA first new 1.0 GHz NMR order comes from the RIKEN Center for Biosystems Dynamics Research<\/a> in Yokohama, Japan. The RIKEN team under Dr. Ichio Shimada will use GHz NMR to study dynamical structures of biomolecules in solution and to investigate the relationships between dynamical structures and biological function or pathobiology.\n<\/p>\n

\nBruker also confirms two 1.0 GHz NMR orders from major research centers and universities in Bilbao and Barcelona, both in Spain, for clinical and biological research:\n<\/p>\n

\nProfessor \u00d3scar Millet, Principal Investigator of the Precision Medicine and Metabolism Lab at CIC bioGUNE<\/a> stated: \u201cThe Ascend Evo 1.0 GHz<\/i><\/b> will advance our research in clinical metabolomics. This novel magnet provides highest-resolution NMR to investigate the molecular patterns and mechanism of action of prevalent and rare diseases in precision medicine, all in a single-story lab and with a smaller footprint.\u201d\n<\/p>\n

\nProfessor Miquel Pons Valles, Group Leader of the BioNMR Group at Universitat de Barcelona<\/a> <\/i>and his team use biophysical methods, especially NMR, as well as chemical biology, molecular biology, and computations to study proteins in regulatory processes, where dynamics is essential for function. The Ascend Evo 1.0<\/i> GHz <\/i>will also advance their research on intrinsically disordered proteins (IDPs).\n<\/p>\n

\nThe recently introduced, compact Ascend Evo 1.0 GHz<\/i><\/b> NMR magnet has significantly reduced footprint, weight, and ceiling height requirements to fit into most single-story laboratories. Along with a 65% reduction in helium consumption, this provides more structural biology principal investigators, individual universities and research centers, as well as advanced biopharma companies access to the sensitivity and resolution of GHz NMR in order to enable new research capabilities.\n<\/p>\n

\nAnother innovation is Bruker\u2019s new Heliosmart Recovery<\/i><\/b>, a compact and easy-to-site system that collects helium boil-off from NMR magnets. Helium gas is stored in high-pressure cylinders, which can be used by cryogen suppliers for reliquification. The Heliosmart Recovery<\/i> system can collect the steady-state boil-off of several NMR magnets in parallel with typical recovery rates of 80% \u2013 85%.\n<\/p>\n

\nDr. Falko Busse, President of the Bruker BioSpin Group, commented: “We are excited to announce the three new GHz orders, which will incorporate our innovative, single-story Ascend Evo 1.0 GHz <\/i>magnet. This technological marvel brings the power of GHz NMR to more laboratories due to its smaller footprint, reduced maintenance requirements and lower Helium consumption.\u201d\n<\/p>\n

\nPlease join Bruker at Euromar<\/a> at our booth for interaction with our NMR and EPR teams.\n<\/p>\n

\nAbout Bruker Corporation (Nasdaq: BRKR)<\/b>\n<\/p>\n

\nBruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker\u2019s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular and cell biology research, in applied and pharma applications, in microscopy and nanoanalysis, as well as in industrial applications. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit: www.bruker.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestors:<\/b>
Justin Ward
\n
Sr. Director, Investor Relations & Corporate Development
\n
Bruker Corporation
\n
T: +1 (978) 663-3660 x1479
\n
E: Investor.Relations@bruker.com<\/a>\n<\/p>\n

\nMedia:<\/b>
Thorsten Thiel, Ph.D.
\n
VP of Group Marketing
\n
Bruker BioSpin
\n
T: +49 7243 769 5500
\n
E: pr@bruker.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Three Labs in Japan and Spain to Receive Novel Compact Ascend Evo 1.0 GHz Magnets UTRECHT, The Netherlands–(BUSINESS WIRE)–$BRKR #BRKR–At the Euromar 2022 Conference, Bruker announced three new customer orders for GHz systems, which will incorporate novel, compact 1.0 GHz NMR magnets for structural biology applications and clinical research in single-story laboratories. The new Ascend … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46005","6":"format-standard","7":"category-industry"},"yoast_head":"\nBruker Announces Three New GHz NMR Systems Orders for Functional Structural Biology and Clinical Phenomics Research - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/bruker-announces-three-new-ghz-nmr-systems-orders-for-functional-structural-biology-and-clinical-phenomics-research\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bruker Announces Three New GHz NMR Systems Orders for Functional Structural Biology and Clinical Phenomics Research - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Three Labs in Japan and Spain to Receive Novel Compact Ascend Evo 1.0 GHz Magnets UTRECHT, The Netherlands–(BUSINESS WIRE)–$BRKR #BRKR–At the Euromar 2022 Conference, Bruker announced three new customer orders for GHz systems, which will incorporate novel, compact 1.0 GHz NMR magnets for structural biology applications and clinical research in single-story laboratories. The new Ascend ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/bruker-announces-three-new-ghz-nmr-systems-orders-for-functional-structural-biology-and-clinical-phenomics-research\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-11T10:02:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220711005260\/en\/1509001\/21\/Photo-Bruker-AscendEvo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bruker-announces-three-new-ghz-nmr-systems-orders-for-functional-structural-biology-and-clinical-phenomics-research\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bruker-announces-three-new-ghz-nmr-systems-orders-for-functional-structural-biology-and-clinical-phenomics-research\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Bruker Announces Three New GHz NMR Systems Orders for Functional Structural Biology and Clinical Phenomics Research\",\"datePublished\":\"2022-07-11T10:02:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bruker-announces-three-new-ghz-nmr-systems-orders-for-functional-structural-biology-and-clinical-phenomics-research\\\/\"},\"wordCount\":703,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bruker-announces-three-new-ghz-nmr-systems-orders-for-functional-structural-biology-and-clinical-phenomics-research\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220711005260\\\/en\\\/1509001\\\/21\\\/Photo-Bruker-AscendEvo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bruker-announces-three-new-ghz-nmr-systems-orders-for-functional-structural-biology-and-clinical-phenomics-research\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bruker-announces-three-new-ghz-nmr-systems-orders-for-functional-structural-biology-and-clinical-phenomics-research\\\/\",\"name\":\"Bruker Announces Three New GHz NMR Systems Orders for Functional Structural Biology and Clinical Phenomics Research - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bruker-announces-three-new-ghz-nmr-systems-orders-for-functional-structural-biology-and-clinical-phenomics-research\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bruker-announces-three-new-ghz-nmr-systems-orders-for-functional-structural-biology-and-clinical-phenomics-research\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220711005260\\\/en\\\/1509001\\\/21\\\/Photo-Bruker-AscendEvo.jpg\",\"datePublished\":\"2022-07-11T10:02:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bruker-announces-three-new-ghz-nmr-systems-orders-for-functional-structural-biology-and-clinical-phenomics-research\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bruker-announces-three-new-ghz-nmr-systems-orders-for-functional-structural-biology-and-clinical-phenomics-research\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bruker-announces-three-new-ghz-nmr-systems-orders-for-functional-structural-biology-and-clinical-phenomics-research\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220711005260\\\/en\\\/1509001\\\/21\\\/Photo-Bruker-AscendEvo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220711005260\\\/en\\\/1509001\\\/21\\\/Photo-Bruker-AscendEvo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bruker-announces-three-new-ghz-nmr-systems-orders-for-functional-structural-biology-and-clinical-phenomics-research\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bruker Announces Three New GHz NMR Systems Orders for Functional Structural Biology and Clinical Phenomics Research\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bruker Announces Three New GHz NMR Systems Orders for Functional Structural Biology and Clinical Phenomics Research - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/bruker-announces-three-new-ghz-nmr-systems-orders-for-functional-structural-biology-and-clinical-phenomics-research\/","og_locale":"en_US","og_type":"article","og_title":"Bruker Announces Three New GHz NMR Systems Orders for Functional Structural Biology and Clinical Phenomics Research - Pharma Trend","og_description":"Three Labs in Japan and Spain to Receive Novel Compact Ascend Evo 1.0 GHz Magnets UTRECHT, The Netherlands–(BUSINESS WIRE)–$BRKR #BRKR–At the Euromar 2022 Conference, Bruker announced three new customer orders for GHz systems, which will incorporate novel, compact 1.0 GHz NMR magnets for structural biology applications and clinical research in single-story laboratories. The new Ascend ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/bruker-announces-three-new-ghz-nmr-systems-orders-for-functional-structural-biology-and-clinical-phenomics-research\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-11T10:02:31+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220711005260\/en\/1509001\/21\/Photo-Bruker-AscendEvo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/bruker-announces-three-new-ghz-nmr-systems-orders-for-functional-structural-biology-and-clinical-phenomics-research\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/bruker-announces-three-new-ghz-nmr-systems-orders-for-functional-structural-biology-and-clinical-phenomics-research\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Bruker Announces Three New GHz NMR Systems Orders for Functional Structural Biology and Clinical Phenomics Research","datePublished":"2022-07-11T10:02:31+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/bruker-announces-three-new-ghz-nmr-systems-orders-for-functional-structural-biology-and-clinical-phenomics-research\/"},"wordCount":703,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/bruker-announces-three-new-ghz-nmr-systems-orders-for-functional-structural-biology-and-clinical-phenomics-research\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220711005260\/en\/1509001\/21\/Photo-Bruker-AscendEvo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/bruker-announces-three-new-ghz-nmr-systems-orders-for-functional-structural-biology-and-clinical-phenomics-research\/","url":"https:\/\/pharma-trend.com\/en\/bruker-announces-three-new-ghz-nmr-systems-orders-for-functional-structural-biology-and-clinical-phenomics-research\/","name":"Bruker Announces Three New GHz NMR Systems Orders for Functional Structural Biology and Clinical Phenomics Research - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/bruker-announces-three-new-ghz-nmr-systems-orders-for-functional-structural-biology-and-clinical-phenomics-research\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/bruker-announces-three-new-ghz-nmr-systems-orders-for-functional-structural-biology-and-clinical-phenomics-research\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220711005260\/en\/1509001\/21\/Photo-Bruker-AscendEvo.jpg","datePublished":"2022-07-11T10:02:31+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/bruker-announces-three-new-ghz-nmr-systems-orders-for-functional-structural-biology-and-clinical-phenomics-research\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/bruker-announces-three-new-ghz-nmr-systems-orders-for-functional-structural-biology-and-clinical-phenomics-research\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/bruker-announces-three-new-ghz-nmr-systems-orders-for-functional-structural-biology-and-clinical-phenomics-research\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220711005260\/en\/1509001\/21\/Photo-Bruker-AscendEvo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220711005260\/en\/1509001\/21\/Photo-Bruker-AscendEvo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/bruker-announces-three-new-ghz-nmr-systems-orders-for-functional-structural-biology-and-clinical-phenomics-research\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Bruker Announces Three New GHz NMR Systems Orders for Functional Structural Biology and Clinical Phenomics Research"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46005","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46005"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46005\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46005"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46005"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46005"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}